United States - English - NLM (National Library of Medicine)

par pharmaceutical, inc. - pimozide (unii: 1hiz4dl86f) (pimozide - unii:1hiz4dl86f) - pimozide 1 mg - pimozide tablets, usp is indicated for the suppression of motor and phonic tics in patients with tourette’s disorder who have failed to respond satisfactorily to standard treatment. pimozide tablets, usp is not intended as a treatment of first choice nor is it intended for the treatment of tics that are merely annoying or cosmetically troublesome. pimozide tablets, usp should be reserved for use in tourette’s disorder patients whose development and/or daily life function is severely compromised by the presence of motor and phonic tics. evidence supporting approval of pimozide tablets, usp for use in tourette’s disorder was obtained in two controlled clinical investigations which enrolled patients between the ages of 8 and 53 years. most subjects in the two trials were 12 or older. 1. pimozide is contraindicated in the treatment of simple tics or tics other than those associated with tourette’s disorder. 2. pimozide should not be used in patients taking drugs that may, themselves, cause motor and phonic tics (

United States - English - NLM (National Library of Medicine)

avera mckennan hospital - pimozide (unii: 1hiz4dl86f) (pimozide - unii:1hiz4dl86f) - pimozide 2 mg

Canada - English - Health Canada

pharmascience inc - pimozide - tablet - 2mg - pimozide 2mg - miscellaneous antipsychotics

Canada - English - Health Canada

pharmascience inc - pimozide - tablet - 4mg - pimozide 4mg - miscellaneous antipsychotics

Canada - English - Health Canada

pharmascience inc - pimozide - tablet - 10mg - pimozide 10mg - miscellaneous antipsychotics

Canada - English - Health Canada

aa pharma inc - pimozide - tablet - 2mg - pimozide 2mg - miscellaneous antipsychotics

Canada - English - Health Canada

aa pharma inc - pimozide - tablet - 4mg - pimozide 4mg - miscellaneous antipsychotics

United States - English - NLM (National Library of Medicine)

teva select brands - pimozide (unii: 1hiz4dl86f) (pimozide - unii:1hiz4dl86f) - pimozide 2 mg

United States - English - NLM (National Library of Medicine)

teva select brands - pimozide (unii: 1hiz4dl86f) (pimozide - unii:1hiz4dl86f) - orap (pimozide) is indicated for the suppression of motor and phonic tics in patients with tourette’s disorder who have failed to respond satisfactorily to standard treatment. orap is not intended as a treatment of first choice nor is it intended for the treatment of tics that are merely annoying or cosmetically troublesome. orap should be reserved for use in tourette’s disorder patients whose development and/or daily life function is severely compromised by the presence of motor and phonic tics. evidence supporting approval of pimozide for use in tourette’s disorder was obtained in two controlled clinical investigations which enrolled patients between the ages of 8 and 53 years. most subjects in the two trials were 12 or older. - orap (pimozide) is contraindicated in the treatment of simple tics or tics other than those associated with tourette’s disorder. - orap should not be used in patients taking drugs that may, themselves, cause motor and phonic tics (e.g., pemoline, methylphenidate and amphetamines) un

Israel - English - Ministry of Health

j-c health care ltd - pimozide - tablets - pimozide 4 mg - pimozide - pimozide - neuroleptic.